Interactive Transcript
0:00
The next case is a 37-year-old female who
0:03
presents with abdominal pain for which a non-
0:05
contrast CT scan of the abdomen was performed.
0:08
As we scroll through these images and we focus on the
0:10
liver, we can see that there are multiple ill-defined
0:14
hypodense lesions scattered throughout the liver.
0:17
We were just to window this to bring them out a little
0:19
bit more, you can see at the dome of the liver there's
0:21
one over here, one over here, there's a couple that
0:24
are a little bit larger, two over here, and, uh,
0:27
all throughout the liver, a bunch of liver lesions
0:29
that are difficult to confidently characterize, and
0:33
an MRI was suggested, uh, for further evaluation.
0:36
So here we have the MRI exam performed for this
0:40
patient, and as we scroll through our, uh, sets of
0:42
T2-weighted images, we can see that the lesions we
0:45
saw in the CT scan were just the tip of the iceberg.
0:48
There are innumerable T2 hyperintense
0:52
lesions scattered throughout this liver.
0:54
And these are pretty well seen in both the T2-weighted
0:56
images as well as the T2 fat-saturated sequence.
0:59
Um, we can see a few of them here, um, for
1:02
example, in the posterior right hepatic lobe.
1:04
Pretty hyperintense on the T2-weighted images with a
1:06
signal that is very close to the cerebrospinal fluid signal.
1:09
So, despite the multiplicity of these lesions,
1:13
given their signal characteristics, I'm not
1:14
too worried about them when I look at them.
1:17
But we also note that a majority of them, for
1:19
example, a whole bunch of them that are scattered
1:21
here in the right and portion of the left
1:23
hepatic lobe are quite small in size, right?
1:26
At most, maybe, one of these lesions may be 15 to 20
1:30
millimeters, but most of them are about 5 to 10 millimeters
1:33
in size, and a lot of them are even smaller than that.
1:36
So that becomes a key imaging feature when
1:37
we talk about what this entity will be.
1:40
As we go through our systematic approach, we're
1:42
then going to go on to the out-of-phase images and
1:44
the in-phase image just to see if there's any fat.
1:47
There are areas of susceptibility within these
1:48
lesions, and we'll just focus on one particular
1:52
lesion or a bunch of lesions seen in this slice.
1:54
This one over here, for example, looks
1:56
like it's hypointense in both the out
1:58
of phase image and the in-phase image.
1:59
It doesn't lose signal.
2:01
As we will scroll through these images, you can see that
2:03
none of the liver lesions lose signal, so they don't contain
2:06
fat; they don't contain areas of increased susceptibility.
2:09
Normally, we would then further evaluate these
2:11
lesions with intravenous contrast; however, for this
2:14
patient, could not get intravenous contrast; therefore,
2:16
we have to make do with the images that we have.
2:18
But, really, there's enough information on the T2-weighted
2:22
sequences to make a diagnosis of what this entity is.
2:26
We can see, again, on the coronal image,
2:28
scattered innumerable cystic lesions, quite small
2:31
in size, seen all over the liver parenchyma.
2:33
Some are a little bit larger, as you can see over here.
2:36
And this turns out to be an
2:37
entity called biliary hamartomas.
2:42
These are also known as von Meyenburg complexes, seen
2:49
equal amounts between males and females, and they're
2:53
seen in up to 3 percent of the general population.
2:55
They're probably more common than we once realized,
2:58
and they're almost always incidental and asymptomatic.
3:01
Patients have normal liver function tests, so,
3:04
nothing going to be abnormal over there, and
3:06
no treatment is really needed for these cases.
3:09
Now, as it turns out, if you look at the pathology
3:11
of these lesions, they can be completely cystic.
3:15
They can be solid or a little bit of a mixed component.
3:18
Certainly when they're completely cystic, they'll
3:20
have this appearance when you see multiple
3:22
tiny cysts scattered throughout the liver.
3:24
They may slowly increase in time, but by and
3:27
large, these are lesions that you don't need to
3:29
worry about, and that you can make a confident
3:32
diagnosis utilizing our MR imaging techniques.
© 2024 Medality. All Rights Reserved.